FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Instagram Outage Disrupts Thousands of U.S. Users 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
 Guidance System Achieves New Clinical Milestone - EconoTimes)
ORLANDO, Fla., March 1, 2016 -- Mazor Robotics (www.mazorrobotics.com), a pioneer in surgical guidance systems for spine and brain surgery, announced today a new clinical milestone with the successful completion of over 150 complex spine cases, performed with the Renaissance® system, by Dr. Kornelis Poelstra, at Sacred Heart Hospital Emerald Coast in Florida.
"Mazor Robotics' Renaissance® system changes the paradigm by removing the guess work in pedicle screw placement," said Dr. Poelstra. "Its precision and versatility makes it my solution of choice for my complex spine cases both open and minimally invasive. I am very pleased to report that my 160 patients are doing great."
This achievement complements Dr. Poelstra's ongoing work with the Mazor Robotics PROlat™ release. PROlat is an application for the Renaissance system in which single position surgery in lateral access spine procedures is facilitated. This technique may result in a shorter length of surgery, which is beneficial to the patient, the surgeon, and the hospital facility.
"We are excited to help surgeons improve spine care," said Christopher Prentice, CEO, Mazor Robotics, Inc. "By leading the way in the transition from free-hand operations to blue-printed mechanical guided procedures, we help both the surgeon community and most importantly, the patients. It is a very exciting time for our organization."
Mazor Robotics will be exhibiting the PROlat application at the upcoming American Academy of Orthopedic Surgeons (AAOS) 2016 Annual Meeting, in Orlando, Florida. (#767).
About Mazor Robotics
Mazor Robotics (TASE: MZOR; NASDAQGM: MZOR) believes in healing through innovation by developing and introducing revolutionary robotic-based technology and products aimed at redefining the gold standard of quality care. Mazor Robotics Renaissance® Guidance System enables surgeons to conduct spine and brain procedures in a more accurate and secure manner. For more information, please visit www.MazorRobotics.com.
CONTACT: Stephani Shipman
Mazor Robotics, Inc.
[email protected]
(407) 591-3461
